As our readers know well, our primary focus here at Save the Cord Foundation is to encourage the preservation of cord blood stem cells which can be used to treat 80+ diseases. Yet, we also recognize the growing importance of perinatal stem cells, cord tissues, uses for the placenta, amniotic membrane, etc. Scientists agree we are just on the tip of the iceberg in understanding how to use these “by-products” of the birthing process more wisely. We should not simply throw them away without asking first. . . do they have a potential second use?
With this thought in mind, Save the Cord Foundation and Mediware, Inc. are proud to announce the next edition in our Share the Science series — a real world example of how the amniotic membrane (a by-product of the birthing process) is currently used in ophthalmology and as well as potential uses for this medical resource in the near future.
UPDATE: RECORDING NOW AVAILABLE, CLICK LINK BELOW — On October 24th, 2017, Save the Cord Foundation and Mediware, Inc. will welcome Dr. Roxana URSEA from the University of Arizona Department of Ophthalmology and Visual Sciences. Dr. Ursea will discuss how the amniotic membrane is currently used and how it can help heal ocular surface disease (OSD). She will discuss its clinical significance, her own research in this area and data from various clinical applications.
According to the Bascom Palmer Eye Institute at the University of Miami, ocular surface diseases affect the “surface of the cornea—the transparent layer that forms the front of the eye. These diseases include dry eye syndrome, meibomian gland dysfunctionblepharitis, rosaceous, allergies, scarring from glaucoma medications, chemical burns, thermal burns, and immunological conditions such as Mucous Membrane Pemphigoid and Sjogren’s Syndrome.
Ocular surface diseases can severely affect eyesight and quality of life. Symptoms may include blurry vision, discomfort or pain, redness and itching, and in severe cases, blindness due to corneal scarring.” (source: Bascom Palmer Eye Institute – OSD overview ).
Use of amniotic membrane for the eye has been common practice for several years and indications for its use have continued to expand. The reasons for its use are numerous. Notably, amniotic membrane, the innermost layer of the placenta, can stabilize the ocular surface. It exhibits strong anti-inflammatory properties, promotes healing without scarring, and supports stem cell expansion. In patients with moderate to severe dry eye, cryo-preserved amniotic membrane plays a role in corneal nerve regeneration and restores corneal nerve integrity.
During this webinar, Dr. Ursea will discuss the important role the amniotic membrane plays in healing a variety of ocular surface diseases. She will share data for how to best utilize these clinical applications. She will discuss in detail how the amniotic membrane can be used as a biological bandage for superficial epithelial defects or as a permanent graft for deeper defects, including stromal defects, post-infectious ulcers, recurrent erosions/endothelial basement membrane dystrophy, small corneal perforations, inflammatory conditions, and chemical burns. She will also cover how it is especially beneficial in ocular surface reconstruction cases as well as in selected post-surgical procedures.
Please join us for this exciting free webinar. . .
Share the Science
Dr. Roxana Ursea
“Clinical Applications of Amniotic Membrane in Ocular Surface Disease”
Tuesday, October 24th | 2 p.m. – 3 p.m. Central Time
Free online webinar – Open to the Public
RECORDING NOW AVAILABLE – REGISTER ONLINE HERE
Attendees will learn about the:
- Role of amniotic membrane in promoting regenerative healing
- Clinical significance of amniotic membrane and the rationale for its use
- Science behind amniotic membrane use and its ocular indications and outcomes, including data from clinical cases
- Pearls and pitfalls in using the amniotic membrane products in your practice
About Dr. Roxana Ursea:
Dr. Ursea is a clinical associate professor of ophthalmology at the University of Arizona Department of Ophthalmology and Visual Sciences. After completing her residency in ophthalmology at New York-Presbyterian Hospital/Weill Cornell and University of Maryland in Baltimore, Dr. Ursea expanded her clinical expertise with specialized training in uveitis and ocular immunology at the National Eye Institute of NIH in Bethesda, Maryland. She completed a second fellowship in cornea, external diseases, and refractive surgery at the University of California in San Diego.
Dr. Ursea is active in many professional organizations and has published in major peer-reviewed journals. She is a recognized national and international expert in ocular imaging, in particular, high-frequency ultrasound, and has received numerous awards, including the American Academy of Ophthalmology’s Achievement Award and the University of Arizona’s prestigious Vernon and Virginia Furrow Award for Excellence in Teaching Clinical Sciences.
Her clinical interests include keratoconus, laser vision correction, and challenging uveitis cases while her research interests include exploring new applications of high frequency ultrasound and new therapeutic modalities for anterior segment disorders. She has an active clinical and surgical practice at Northwest Medical Center in Tucson, Arizona.
Save the Cord Foundation wishes to thank Dr. Ursea
for sharing her valuable insight and expertise
with our Share the Science community.
We also wish to thank Mediware, Inc.
for their continued generous support of this program.
Share the Science continues to be a popular series within the cord blood community and beyond. We welcome your input on the series and suggestions for future speakers. Give your feedback here.
Share the Science is made possible thanks to the generous support of Mediware, Inc.